Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DTW domain containing 2 pseudogene (ENSG00000267648) is a human pseudogene related to the protein-coding gene DTWD2, which encodes the enzyme tRNA-uridine aminocarboxypropyltransferase[1][5]. This pseudogene does not produce a functional protein product and instead represents a non-coding genomic sequence that has lost its original coding potential, likely through mutation or genetic rearrangement[1][7][11]. Such pseudogenes are classified as either processed or unprocessed, lacking regulatory or coding capacity of their parental genes[7][11]. While some pseudogenes are known to influence gene regulation through RNA-based mechanisms (as decoys for microRNAs, for example), there is no current evidence suggesting any active biological or pathological role for this specific pseudogene.\n\nKey point: This target is a non-functional pseudogene and is not a druggable entity or receptor. If your goal is to find a therapeutic target, refer to the protein-coding gene "DTW domain containing 2 (DTWD2)" instead[5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DTW domain containing 2 pseudogene.